Peptides are everywhere right now, and most of what you read is either hype, fear, or someone trying to sell you something. Here are the straightforward, honest answers. No fluff, no selling you anything: just what the research actually shows, what doctors and the FDA say, and how to explore them without getting burned.
Free to read. We don't sell peptides and we never link to gray-market vendors.
Sixty seconds of plain English before the deeper stuff. If you already know what a peptide is, skip ahead.
A peptide is a short chain of amino acids, the same building blocks that make up proteins. Your body already makes thousands of them, including hormones like insulin. Most peptides work as signaling molecules that tell your cells what to do. The catch: "peptides" covers everything from FDA-approved medicines to unregulated vials sold online, so what matters is always which peptide, and where it comes from. A handful of peptide medicines have very strong evidence behind them: GLP-1 peptides like semaglutide (Ozempic, Wegovy) have helped millions of people reach a healthier weight, according to Harvard Health Publishing.1 Most other wellness peptides sold online do not have that level of evidence.
The full explainer: what are peptides? →Four straight answers, each backed by named sources. Read the one that matches where you are.
The danger is rarely the molecule. It's the supply chain. Here's the difference between a prescribed peptide and a vial off the internet.
Read the safety guide →What "research use only" really means, why it's a loophole, and where the FDA has drawn the line in 2026.
Read the legal breakdown →How to tell a real clinic from a storefront, the questions to ask, and why the licensed route is worth the extra cost.
See the safe path →Two doors: a licensed telehealth clinic, or a "research use only" vendor that isn't for humans. How to tell them apart.
Compare the two routes →Promising in animal studies, almost untested in humans, not FDA-approved. The honest status of the most-searched peptide.
See the evidence →Weight loss, muscle, healing, side effects, cost. The fast facts, then a link to the full evidence.
Jump to FAQ →The same compound can come from a supervised medical channel or an unregulated seller. These two paths could not be more different.
This is the whole game. Most peptide horror stories trace back to the right column, not to peptides being inherently dangerous. See how to stay in the left column →
An evidence-based account of what is established, what is preliminary, and what remains unknown — sourced from the FDA, Stanford Medicine, Harvard Health, and published clinical trials.
The question "are peptides good?" is almost impossible to answer in the abstract, because the word "peptide" covers a range that stretches from some of the most studied medicines in human history to vials sold online with almost no human safety data. The evidence on that spectrum is not evenly distributed, and conflating one end with the other is the source of most of the confusion you'll find online.
Peptide medicines have a decades-long track record in formal medicine. According to Stanford Medicine, the FDA has approved roughly 100 different peptide therapeutics since injectable insulin first became available — covering conditions from diabetes to HIV-associated lipodystrophy to multiple sclerosis.4 These compounds went through the full regulatory process: human safety trials, large-scale efficacy studies, documented side effect profiles, and defined dosing guidelines before any patient received them.
The GLP-1 receptor agonists are the most visible recent example. Semaglutide, the active compound in Ozempic and Wegovy, completed a large phase III trial — the STEP 1 study — that enrolled 1,961 participants and ran for 68 weeks before the drug reached physicians. In that trial, 86.4 percent of participants in the treatment group achieved at least 5 percent weight loss, compared with 31.5 percent on placebo.5 That is what rigorous human evidence looks like: a defined population, a control group, a long timeline, and documented side effects weighed against measurable outcomes. A 2024 CDC National Health Interview Survey found that 26.5 percent of U.S. adults with diagnosed diabetes reported using GLP-1 injectable medications — a reflection of how rapidly this class has moved into mainstream clinical practice.6
Not all peptides are anywhere near that level of study. This table maps where the most commonly discussed compounds sit on the evidence spectrum — not based on marketing claims, but on the current state of published human data.
| Peptide | Human safety data available | FDA status | Evidence grade |
|---|---|---|---|
| Insulin | 100+ years of clinical use; extensive data | Approved (multiple indications) | Highest — among the most studied molecules in medicine |
| Semaglutide (GLP-1) | Multiple large phase III trials; 1,961 participants in STEP 1 alone | Approved (obesity, type 2 diabetes) | High — robust human efficacy and safety data |
| Tesamorelin | Phase III trials completed | Approved (HIV-associated lipodystrophy) | High — within its approved indication |
| BPC-157 | 2 people in one pilot IV study (2025) | Not approved; removed from most compounding | Very limited — animal data only for most claims |
| TB-500 (Thymosin β-4 fragment) | No published human safety trials | Not approved; removed from most compounding | No human data |
| CJC-1295 / Ipamorelin | No published human safety trials; FDA flagged serious adverse events for Ipamorelin | Not approved; Ipamorelin removed from compounding | No human data; regulatory caution noted |
| GHK-Cu (injectable) | No published human injection safety trials | Not approved for injection; removed from compounding | No human data for the injectable route |
Even setting aside the evidence question, where a peptide comes from determines its practical safety in ways that the molecule itself does not. A large share of wellness peptides available online carry a "research use only" label. That label means the product is legally sold for in vitro laboratory research — not intended, tested, or regulated for human use. There is no federal requirement that a research-use-only product meet pharmaceutical-grade purity or sterility standards before it ships to a buyer.
The American Medical Association has specifically warned against self-injecting peptides obtained this way, citing contamination and dosing risks as the primary concerns.2 Published analytical chemistry research examining peptides sourced from suspected illegal internet pharmacies has found purity as low as 5 percent in certain cysteine-containing samples — meaning up to 95 percent of a vial's contents were impurities rather than the labeled compound. Several samples in that research contained arsenic at concentrations up to ten times the International Council for Harmonisation toxicity limit for injectable drugs.
Harvard Health Publishing notes that injectable peptides sold this way "could trigger abnormal immune system responses, leading to allergic reactions (including severe ones like anaphylaxis) or autoimmune issues in some people."1 This is not a risk that any standard side-effect list captures, because it relates to contamination and immune response rather than the labeled compound's known pharmacology.
U.S. peptide-related online searches hit an estimated 10.1 million per month in early 2026 — roughly five times the volume seen in 2020 — according to wellness industry tracking data. The commercial interest in peptides has grown dramatically and much faster than the clinical research that could justify most wellness applications.
This gap is part of what makes the category confusing. GLP-1 peptides like semaglutide are legitimately among the most significant metabolic medicines in recent history, with a substantial evidence base and FDA approval for defined indications. That genuine success has created a halo effect around the broader "peptide" category, even though most wellness peptides being sold online share nothing with semaglutide except belonging to the same molecular class.
As Harvard Health Publishing notes, online health claims about peptides "have not been vetted by any expert group, the FDA, or anyone else. The health claims are divorced from data." The evidence that exists for proven peptide medicines does not transfer to unapproved compounds simply because they share a label.
The regulatory picture for wellness peptides has shifted noticeably. In late 2023, the FDA moved 19 commonly used wellness peptides — including BPC-157, TB-500, and several growth-hormone-releasing compounds — off the list of substances that licensed compounding pharmacies could legally prepare, citing limited safety data and identified risks.7 In July 2026, an FDA advisory committee voted 8 to 6 (with one abstention) to recommend reconsidering some of those restrictions, a narrow margin that reflects how genuinely unsettled the evidence base remains even among the specialists who track it most closely.
The FDA's ongoing actions reflect the same distinction that matters throughout this site: the agency has approved roughly 100 peptide therapeutics that went through proper human testing, while simultaneously tightening access to compounds that have not. The two tracks exist simultaneously because "peptide" describes a molecular structure, not an evidence level. More on the regulatory picture is on our peptide legality page.
Understanding what peptides actually are — as a class of molecules — is useful context before evaluating any specific compound. Our full explainer on what peptides are covers the biology, the vocabulary, and why the category is so broad. And if you are actively weighing whether to try a peptide, our guide on the safest way to try peptides walks through exactly how to evaluate a clinic and what to ask a provider.
We're not selling peptides, so we have no reason to oversell them. Here's the standard every page is held to, written and maintained by Dana Marsh, an independent health & science writer.
Every claim ties back to the FDA, a major medical institution, or peer-reviewed research, not to a supplement brand.
We say plainly when a result is only shown in mice. "Promising in a rat study" is not "proven in you."
We won't promise a peptide cures anything, and we won't pretend the whole category is a scam. Just the evidence.
Every page shows when it was last reviewed, because the science and the regulations keep moving.
"When you're talking about peptides being promoted online, those health claims have not been vetted by any expert group, the FDA, or anyone else. The health claims are divorced from data."
— Dr. Pieter Cohen, Associate Professor of Medicine, Harvard Medical School, in Harvard Health Publishing (July 2026)1
Read the one page that matters most before you spend a dollar: how to tell a legitimate, licensed provider from an unregulated seller, and the exact questions to ask.